Lee Su-jin, CEO of MetaCare: "Combining Chinese Robots with K-Clinical Trials, Targeting Global AI Hair Transplant Market"
Predicted impact: Low
CEO interview on strategy; no financial figures or concrete event.
Metacare메타케어
118000 · KOSPI · ₩118000 · 메타케어
₩1,298▼ ₩22 (1.67%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y −57.44%
- Market cap
- ₩29B
- Enterprise value
- ₩89B
- P/E
- —
- P/B
- 0.2×
- Dividend yield
- 0.0%
- ROE
- −1.3%
- Net margin
- −4.0%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−65.7% from the high
₩1,001Today: ₩1,249 – ₩1,423₩3,780
Returns
- 1W+6.6%
- 1M+1.8%
- 3M+13.4%
- 6M−37.6%
- YTD−57.4%
- 1Y−57.4%
- Volume today
- 287,234
- 3.9× the 20-day average
- Traded today
- ₩351M
- Listed shares
- 22,055,785
- EPS (12 months)
- −₩72
- Earnings yield −5.6%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
−1.7% on Oct 28, 2026. Trading value 3.7× its normal.
- • Filing: Insider shareholding report
- • Foreign investors bought a net ₩5.1M that day
- • Buzz 63 on JONBUR: heavy trading
Possible reasons, not certainties. Not financial advice.
Signals
Warming up- BuzzRisingBuzz 63: heavy trading.
- MomentumFlat2% over the last month; the price is above its 20-day average.
- News impactSome5 news items and filings in two weeks; 0 rated high impact, 2 medium.
Signals describe activity, not recommendations. Not financial advice.
Metacare stock overview
Metacare (메타케어, KRX: 118000) is listed on KOSPI, in the Retail & Trade sector. Metacare is a South Korean company operating three business segments: pharmaceuticals, medical devices and supplies, and real estate development. Its shares closed at ₩1,298 on Oct 28, 2026, down 1.67% on the day, giving it a market value of ₩29B.
Key facts
- Market cap
- ₩29B
- Sector
- Retail & Trade
- Latest price change
- −1.67%
- As of
- Oct 28, 2026
- Main business
- Metacare is a South Korean company operating three business segments: pharmaceuticals, medical devices and supplies, and real estate development.
Quick answers about Metacare
- What does Metacare do?
- Metacare is a South Korean company operating three business segments: pharmaceuticals, medical devices and supplies, and real estate development. Its pharmaceutical business sells drugs and was expanded through the acquisition of JNS Pharm, while its medical segment supplies medical devices and consumables, including artificial joint materials, to general hospitals. Through subsidiaries, it also provides management consulting and MSO services to hair transplant and hairline clinics, and it leases non-residential buildings in urban areas, mainly in Seoul.
- What is the market cap of Metacare?
- The market capitalisation of Metacare was ₩29B at the close on Oct 28, 2026.
- Who are the largest shareholders of Metacare?
- According to the latest official filings, the largest reported holders are MetaLabs (51.15%, as of Jun 29, 2026); Alpenroute Asset Management (9.48%, as of Sep 18, 2025); Cheongdam Mayhills New Technology Partnership (4.99%, as of Mar 4, 2026).
- When is the next earnings report from Metacare?
- Korean companies rarely announce results dates in advance. Based on when Metacare filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Metacare?
- Yes. The National Pension Service held 0.00% of Metacare shares as of Dec 31, 2024.
Company profile
Metacare is a South Korean company operating three business segments: pharmaceuticals, medical devices and supplies, and real estate development. Its pharmaceutical business sells drugs and was expanded through the acquisition of JNS Pharm, while its medical segment supplies medical devices and consumables, including artificial joint materials, to general hospitals. Through subsidiaries, it also provides management consulting and MSO services to hair transplant and hairline clinics, and it leases non-residential buildings in urban areas, mainly in Seoul.
Written by AI from the company's latest annual report.
- Korean name
- 메타케어
- Sector
- Retail & Trade
- Themes
- —
- CEO
- 이수진
- Founded
- Dec 2009
- Listed
- Dec 2009
- Listed shares
- 22,055,785
- Fiscal year ends
- Month 12
- Website
- www.meta-care.co.kr
Similar companies
- Samsung C&T028260 · ₩53T₩324,500+7.81%
- POSCO International047050 · ₩8.8T₩49,750−0.20%
- ISC095340 · ₩3.5T₩165,900+9.65%
- Youngone111770 · ₩3T₩67,700−0.59%
- Dong SUH Companies026960 · ₩2.7T₩27,400−0.36%
- Shinsegae004170 · ₩2.4T₩257,500+5.10%
- Lotte Shopping023530 · ₩2.4T₩83,700+2.95%
- SK Gas018670 · ₩2.3T₩250,500+0.60%
Recent news
Recent filings
See all- Insider shareholding reportOct 29, 2026
- Preliminary earnings (consolidated)Oct 26, 2026
- Corporate value-up planOct 21, 2026
- Investment Caution Notice (Advance Notice of Risk of Designation as Administrative Issue)Oct 21, 2026
- Merger Completion Report (Merger)Oct 1, 2026
Titles in Korean until English translations are added.
Also known as: Metacare / 메타케어 / 118000 / KRX:118000
Source: KRX statistical information